| dc.contributor.author | Arca Suárez, Jorge | |
| dc.contributor.author | Corrales-Cuevas, Manuel | |
| dc.contributor.author | Pascual-Pérez, Susana | |
| dc.contributor.author | Trujillo-Soto, Teresa | |
| dc.contributor.author | Fernández-Gutiérrez del Álamo, Clotilde | |
| dc.contributor.author | Rodríguez Iglesias, Manuel Antonio | |
| dc.contributor.author | Girón González, José Antonio | |
| dc.contributor.other | Biomedicina, Biotecnología y Salud Pública | es_ES |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2024-11-21T09:05:55Z | |
| dc.date.available | 2024-11-21T09:05:55Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 1435-4373 | |
| dc.identifier.issn | 0934-9723 | |
| dc.identifier.uri | http://hdl.handle.net/10498/33874 | |
| dc.description.abstract | Human immunodeficiency virus (HIV) antibodies have been proposed as a measure of the size of the HIV reservoir. The aim of our study is to quantify the anti-HIV antibodies level in a cohort of people living with HIV (PLWH), stratified based on the presence of continuous undetectable HIV viral load and the co-existence of hepatitis C virus infection. A sample of 229 HIV-monoinfected (n = 114) or HIV/HCV-coinfected [either with resolved HCV infection (n = 75) or active HCV coinfection (n = 40)] patients, followed up a median of 34 (IQR 20-44) months, was studied. Anti-HIV index was obtained as the 1:800 dilution of HIV antibodies. CD4+ T cell count, time with undetectable HIV viral load, annual increase of CD4+ T cell count, anti-HCV therapy, and diagnosis of cirrhosis were analyzed. Patients with a continued suppressed HIV viral load had significant lower anti-HIV index compared with those with virologic failure during the follow-up. Significant higher CD4+ T cell increase was observed in those with a lower anti-HIV index. HIV-monoinfected patients showed an anti-HIV index significantly lower than patients with HCV coinfection. Resolved HCV infection after interferon-based therapy, but not with direct acting antivirals, was associated with a lower anti-HIV index. HIV/HCV-coinfected patients showed higher HIV antibodies level when compared with HIV-monoinfected individuals. A decrease in anti-HIV index in HIV/HCV-coinfected patients was detected when a sustained virological HCV response was obtained after interferon-based therapy, in possible relation with the direct or indirect effect of interferon on PLWH CD4 T cells. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | SPRINGER | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1503-1512 | es_ES |
| dc.subject | HCV infection | es_ES |
| dc.subject | HCV infection treatment | es_ES |
| dc.subject | HIV antibodies level | es_ES |
| dc.subject | HIV reservoir | es_ES |
| dc.title | HIV antibodies level as a marker of HIV persistence: the role of hepatitis C virus coinfection | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | closed access | es_ES |
| dc.identifier.doi | 10.1007/S10096-020-03875-Y | |
| dc.type.hasVersion | VoR | es_ES |